Compare SCTX & FTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCTX | FTW |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.1M | 336.7M |
| IPO Year | 2026 | 2026 |
| Metric | SCTX | FTW |
|---|---|---|
| Price | $27.59 | $11.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 187.6K | 99.9K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $9.50 |
| 52 Week High | $26.50 | $17.20 |
| Indicator | SCTX | FTW |
|---|---|---|
| Relative Strength Index (RSI) | 63.58 | 35.05 |
| Support Level | $19.09 | $11.12 |
| Resistance Level | N/A | $12.42 |
| Average True Range (ATR) | 2.75 | 0.25 |
| MACD | 0.21 | -0.00 |
| Stochastic Oscillator | 96.86 | 25.02 |
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Presidio Production Co is a U.S.-based energy company focused on acquiring, operating and optimizing mature oil and gas assets with a disciplined, technology-driven model.